I look at it the same way. They stated that if the milestones were not met to get the non toxic financing that alternative sources were being evaluated but didn't state if they were non toxic but in any case would close on new capital in 3rd qtr 2016, "which is imperative to increasing shareholder value". I take that to mean that the new debt could be toxic/convertible financing if it comes right down to it. JMO
"The $.01 milestone is a way to get all 450+ shareholders supporting the company to generate funding to increase sales. If we don't achieve it, it will be a missed opportunity for that one financing. However, there are always alternate plans and strategies to create shareholder value."